chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received HPV, hepatitis A, and  hepatitis B vaccines. Was educated about dizziness or fainting feeling potentially after HPV vaccine. Patient walked to checkout desk with mom. Patient stated to mom that she was not feeling well and fainted. Desk staff alerted nursing who alerted the providers as well. Patient did not hit head. Was positioned to her back and legs lifted. Eventually moved to room where vital signs were taken and she was given apple juice and graham crackers. Physician evaluated patient and found patient was safe to go home. No injuries found.
Post vax, the pt developed left facial twitching, her right eyelid wouldn't close, and the left side of her mouth turned upward. Dx with Bell's Palsy.
feeling achy; tired; headache; bad diarrhea; fever; sick; Extreme lethargy; can't sleep; rash; This is a spontaneous report from a contactable consumer (patient). A 69-years-old female patient (no pregnant) received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 05Mar2021 09:15 (Lot Number: EN6206) at age of 69-years-old as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included High blood pressure, high blood sugar, high cholesterol. Concomitant medications included rosuvastatin calcium (CRESTOR); levothyroxine; hydrochlorothiazide, olmesartan medoxomil (OLMESARTANA + HIDROCLOROTIAZIDA).  The patient previously took codeine and experienced drug hypersensitivity.  The patient experienced feeling achy, tired, headache, bad diarrhea, fever, sick, extreme lethargy, can't sleep, rash on 06Mar2021 03:00 with outcome of recovered with sequelae.  The patient received Pepto-Bismol. No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Patient developed itchiness under the left arm on ribs, gave 10ml oral benadryl and symptoms were beginning to resolve after approximately 30 minutes.
Went to ER on 05/28/21 with acute SOB--dx with PE. Notified by person, confirmed by hospital.
12/28 vaccination 12/29 24 hours later, started fatigued, chills, developed into fever. Couldn't eat. Temp was close 100.2 but didn't last long. 99 temp by 3am. By morning it was down to 98. Did not take any medications. HA ,fatigue symptoms lasted  a couple days.  12/30 Went to urgent care.  COVID; negative  12/31 vaccine follow up and return to work
Pt received Flublok on 120422 @ 3:00pm. Reported no allergies or any reactions to vaccines before, before recevieng the shot. @ around 4:42pm, she reported having hives starting from her stomach and spreading to entire body, itching, swelling with redness. advised pt to take benadryl and monitor symptoms, and if not getting any better or becoming worse, go to ED to seek medical help.
Received 3rd RABAVERT am of 4-24-13 and client report felt fine until 8 pm had slight nausea then developed body aches and headache and temp of 102.5 around 4 am on 4/25/13 that broke by 7 am and then had a headache that lasted until around noon on 4/25/13.
menstrual changes; This is a spontaneous report from a Pfizer-sponsored program. A contactable other HCP (patient, nursing student) reported that a 19-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not reported), via an unspecified route of administration on 14Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated she had some menstrual changed after getting the first dose of the vaccine in Apr2021. The outcome of the event was unknown. This report was reported as non-serious.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
9SEP92 pt recvd vax & devel nausea, joint pain, sweats, weakness & fever; treated w/red rest; sx lasted until 6PM; next day;
Patient just turned 12 two days ago and received a 5 to 11-year-old Pfizer dose instead of the 12 years and older.
My first Moderna vaccine was received on 1/27/21. The day after I developed a headache and ringing in my ears. The headache lasted a week but the ringing in the ears has not stopped as of this date.
This spontaneous report was received from a male consumer and refers to his wife. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX for shingles prophylaxis (dose, frequency, route of administration, lot number and expiration date were not reported). It was reported, that the vaccination was failed and the patient had to have a booster vaccine in 60 days (vaccination failure). The outcome of the event was not reported. The causality for the event was not reported. This is one of two cases received from the same reporter. Sender's Comments: US-009507513-1809USA004485.
Tested positive; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced COVID-19 (Tested positive). At the time of the report, COVID-19 (Tested positive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Very limited information regarding this event has been provided at this time. The patient probably experienced asymptomatic COVID-19 infection before being administered with the mRNA-1273 vaccine
Stated (1) hour after vaccine started having itching, redness, swelling and discomfort "sore", from (R) elbow to shoulder. To TYLENOL PM at 8 pm before bedtime. Pain has not subsided, pain (R) wrist to (R) shoulder today 10-9-15.
Guillain-Barre Syndrome. Symptoms started last week of May. Improved with IVIG. Discharge from hospital around 6/20/10.
Extreme dizziness; Vertigo symptoms; Nausea; Mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 18Mar2021 at 12:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included newly diagnosed diabetes in Jan2021, high cholesterol. Prior to vaccination, the patient was diagnosed with COVID-19. The patient had allergy to medicine with sulfa. Concomitant medications included metformin (MANUFACTURER UNKNOWN), rosuvastatin calcium (CRESTOR), berberine (MANUFACTURER UNKNOWN) chromium (MANUFACTURER UNKNOWN) and trigonella foenum-graecum (FENUGREEK) all since an unknown date for unknown indication. Since vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021 at 23:15, within 11 hours after vaccination the patient experienced extreme dizziness and vertigo symptoms. Upon laying down, the room would spin for 20 seconds and when showering room was spinning. The patient also experienced nausea and mild headache after dizziness episodes. These events occurred multiple times daily with 72 hours of time period. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the extreme dizziness, vertigo symptoms, nausea and mild headache were resolved on 21Mar2021.  No follow-up attempts are needed. No further information is expected.
Information has been received from a pharmacist concerning a male in his sixties who on unspecified dates in September 2007 during a vaccination clinic, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included influenza virus vaccine (unspecified). In September 2007 one or two days following vaccination with pneumococcal 23v polysaccharide vaccine the patient present to his physician with injection site reaction described as a cellulitis. The patient was given a prescription for antibiotic (name unspecified). The relationship of the event to therapy with pneumococcal 23v polysaccharide vaccine was report as unknown. The outcome of the event was not reported. No product quality complaint was involved. Additional information has been requested.
Patient describes swollen, warm, red injection site.  Physician husband suspects infection, and they will see PCP tomorrow.
A nurse reported the occurrence of an injection site reaction in a 4 year old female who was inadvertently vaccinated with DTAP (Infanrix) for prophylaxis. The vaccine provider submitted this report directly to VAERS.  The pt had no medical history, concurrent conditions, or concurrent medications. The pt received the first injection of DTAP on 07/22/99.  That day, she cried for five hours. The pertussis immunization series was discontinued. On an unspecified date in 2003, the pt inadvertently received an injection of Infanrix (Lot # DTPA575A2) for the fifth dose in the DT immunization series. At an unspecified time post-immunization, she developed an injection site reaction characterized by redness and induration. She also had a "grump demeanor". The events resolved after 72 hours. The  nurse considered the events to be related to Infanrix administration.
Had a large left-sided subdural hematoma, underwent a left sided craniotomy evacuation. Has had some periods of expressive dysphasia. Serial CT scans revealed no large accumulation. We decided to just leave the drain in and she has resolved. ED visit and hospital admission were within 6 weeks of receiving the COVID vaccine
Information has been received from a registered nurse concerning a 13 month old male who on 6/27/03 was vaccinated with a dose of varicella virus vaccine live (lot # 643587/0803M). On 8/21/03 the patient developed a varicella outbreak. There was no fever and there were less than 50 lesions. The patient was recovering without any complications. Unspecified medical attention was sought. There was no product quality complaint. The reporter also mentioned other patients who developed adverse events (WAES0411USA02898 and WAES0412USA00269). Additional information has been requested.
Fatigue, muscle pain, joint pain, chills, nausea, and fever. Observed 9am juts 25 hours after dose 1. Fever normal at 9am, 10:30 - 100.6,and 11:30am - 101.4.
3pm - Tired and woozy. 10 pm- stiff and sore neck and shoulders. Sometime after 1am- sore muscles and wracking chills. 5am - dry heaving. Slept all the next day with little energy to use restroom or get a drink. Day 3 - more energy and chills gone; able to eat.
sore in her arm; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported) via an unspecified route of administration on 01Mar2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient said that she didn't have any issues or problems to report except for a little sore in her arm on an unspecified date. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (pain in her ear/ear popped/ear started to hurt/Her ear hurts and hurts), HEARING DISABILITY (could not hear anything/she had to make it a lot louder to hear something), FEELING ABNORMAL (feels as if water was going to come out of her ear but nothing comes out, she think it might be leaking inside/ she was desperate and felt bad bad bad), VACCINATION COMPLICATION (some side effects but it's not as bad as with the second dose) and PAIN IN EXTREMITY (leg hurts) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0225210 and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported.On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On 12-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2022, the patient experienced EAR PAIN (pain in her ear/ear popped/ear started to hurt/Her ear hurts and hurts), HEARING DISABILITY (could not hear anything/she had to make it a lot louder to hear something), FEELING ABNORMAL (feels as if water was going to come out of her ear but nothing comes out, she think it might be leaking inside/ she was desperate and felt bad bad bad) and VACCINATION COMPLICATION (some side effects but it's not as bad as with the second dose). In January 2022, the patient experienced PAIN IN EXTREMITY (leg hurts), HEADACHE (a lot of pain in her head) and ARTHRALGIA (knee hurts (which has liquid in it)/ hip hurts). The patient was treated with IBUPROFEN for Headache, at a dose of 600 milligram every six hours. At the time of the report, EAR PAIN (pain in her ear/ear popped/ear started to hurt/Her ear hurts and hurts), HEARING DISABILITY (could not hear anything/she had to make it a lot louder to hear something), FEELING ABNORMAL (feels as if water was going to come out of her ear but nothing comes out, she think it might be leaking inside/ she was desperate and felt bad bad bad), VACCINATION COMPLICATION (some side effects but it's not as bad as with the second dose), PAIN IN EXTREMITY (leg hurts), HEADACHE (a lot of pain in her head) and ARTHRALGIA (knee hurts (which has liquid in it)/ hip hurts) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):In January 2022, SARS-CoV-2 test: inconclusive (Inconclusive) covid test but she does not have the result yet.No concomitant drug details were reported.Patient took anti-inflammatory drugs some days before receiving the dose to prevent side effects.After her shot she had an appointment with her dentist, they did not make any interventions just checked her.Patient reported she is going to have surgery because of her broken ribs. This case was linked to MOD-2021-377075 (Patient Link).
Dose administered after beyond use time for vaccine. 6 hours and 13 minutes had elapsed since first dose was drawn from vial which exceeds Pfizer recommended time frame of 6 hours.
(R) arm unable to lift, feels heavy about 24 hours after injections. Developed "baseball size" lump in upper arm that did not go away until 6-7-11. She had spoke with several docs during the last several months, chiropractor indicated more physical reaction, "like nerve" that could take up to 12 months. 6-9-11 reports lump is gone and has full use of (R) arm.
This spontaneous report as received from a certified medical assistant refers to a 10 week old premature female patient with hydrocephalus and no drug reactions/allergies. There was no concomitant medication. On 04-MAR-2015, the patient was vaccinated with the first dose of PEDVAXHIB (lot # K015463, expiration date: 09-JUL-2017, dose and route not reported). On approximately 18-MAR-2015, reported as 2 weeks after receiving the vaccine, the patient developed abscess at the injection site. The area of the abscess was swollen and bumpy. On 22-MAR-2015, the patient was hospitalized overnight. The patient was treated with clindamycin. No labs/diagnostic studies were performed. The outcomes of the events were reported as recovered/resolved on an unknown date in 2015. The causality between the events and PEDVAXHIB was not reported. The reporter stated she would like a lot check on PEDVAXHIB that was administered. Additional information has been requested.
felt tired; achy; Initial information received on 16-Dec-2020 regarding an unsolicited valid non-serious social media case received from a consumer (patient).  This case involves a patient with an unknown demography who felt tired (fatigue) and achy (pain), while he/she received INFLUENZA VACCINE.  The patient's medical treatments, vaccinations, concomitant medications and family history were not provided.  At the time of the event, the patient had ongoing medical history of arthritis.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, (unknown latency) after administration of INFLUENZA VACCINE, patient felt tired (fatigue) and achy (pain).  The patient did not experienced these events this year when he/she had flu shot.   No laboratory data was provided.  It was not reported if the patient received any corrective treatment.  The events outcome was unknown, at the time of reporting.  There would be no information available on batch number for this case.
pt recv vax; had grand mal sz today, in er; addtl info recv 30aug95;was adm to hosp under care of neurologist;MFR was notified;
I started feeling fatigued about 3 hours after vaccination.  By evening I felt sickly (How you might feel at the onset of a cold) and I started getting a bad headache.  The headache lasted for 48 hours.  It was severe and I had to stay in bed.   I am just now starting to feel a little. better
2  hours after injection, patient developed erythema, pain and swelling at injection site. Then soreness in proximal cervical spine and generalized myalgia and fever. Was prescribed cephalexin 500mg 3x daily x 5 days and Prednisone 20mg x 5 days.
Received vaccine on 01/13/21, woke up on 01/21/21 with severe pain, redness, swelling in arm where injection was placed. Had no previous reaction from vaccine other than slight soreness for 2 days psot vaccine until 01/21/21.
First pregnancy, due date 8-11-2021  Adverse effects: - mild headache for 1-2 hours (went away after taking Tylenol) - sore arm at site of injection
Headache, Myalgia, Fever, TINGLING, TIGHTNESS SCALP Narrative:
Immediately post-vaccination patient had emesis x1 with nausea.  Resolved with supportive management.
Nauseous; Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 17Mar2021 11:00 (Lot number: EN6204) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose-1, single, Lot Number: EN6202), for COVID-19 Immunisation. The following information was reported: NAUSEA (non-serious) with onset 19Mar2021, outcome "unknown", described as "Nauseous"; FATIGUE (non-serious) with onset 17Mar2021, outcome "unknown", described as "Tiredness".  No follow-up attempts are possible. No further information is expected.
Information has been received from an unspecified reporter via a company representative, referring to two unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with a dose of PNEUMOVAX 23 lot # M038359 with an expiration date on 13-MAY-2018, therapy route reported as "one injection per patient" (strength, dose, anatomical location and administration route were not reported) for prophylaxis. On unspecified dates, the patients experienced "major swelling at the injection site" after receiving the PNEUMOVAX 23. The reporter stated that the patients received an unspecified treatment for the event. The outcome of the injection site swelling was reported as recovered and the causality between the vaccination with PNEUMOVAX 23 and the event was not provided. No product quality complaint (PQC) was involved. Additional information has been requested.
pt says she had a sore arm and she woke up had 100.5 fever, headache, nausea, chills, fatigued, body aches and joint pain.  These symptoms lasted about 24 hours.
technician went to administer vaccine and syringe/needle malfunctioned causing the immunization to spew out of syringe down patient arm. patient armed was cleaned and new immunization was administered
Received vaccine on 3/14/22. On 3/15/22, I noticed pain in my right arm radiating to my mid back and assumed it would go away. The next morning, I woke up and couldn't move my arm due to extreme pain. I went to the doctor and was prescribed a muscle relaxer and told to take ibuprofen and tylenol. I tried this with no relief. On 3/18/22, I started having numbness in my fingers and increased pain so I went to the ED. I was prescribed pain medication and started a prednisone taper. The pain and numbness have not subsided. I am unable to work and followed up with my doctor on 3/22/22. I have been placed on a medical leave since I can't perform my duties as a registered nurse,
extreme pain in arm that has spread to the shoulder.     2+months  there is constant pain in the arm and shoulder and loss of mobility in the shoulder   increase in number of headaches
Patient reported feeling slight dizziness after receiving the first Moderna Covid vaccine.  Vitals were taken: BP 120/70, P 78, R 18, T 96.7.  Patient was monitored an additional 10 minutes and the assessed by Dr. after which patient was released from clinic.
a fever; This is a spontaneous report from a non-contactable consumer. This consumer (patient) reported that a 37-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247) via an unspecified route of administration at the age of 37-years, on 26Jan2021 at single dose for COVID-19 immunization, in workplace clinic. There was no other medical history, no known allergies, no other vaccine in four weeks, no COVID-19 prior vaccination. Concomitant medications were not reported. At 18:30 (06:30 PM) on 26Jan2021, the patient developed a fever overnight after receiving first dose. No treatment received. Outcome of the event was recovered/resolved in Jan2021. No COVID-19 tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Information has been received on 05-FEB-2019 from a lawyer and a female patient regarding a case in litigation. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported) on or about June-2013 at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster also known as shingles and other complications. The patient was treated at a health clinic for a blistering vesicular outbreak which was diagnoses as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Right arm swelling with fever, redness, & tightness. Area larger than fist. No complaints of difficulty breathing or pain away from injection site. Pt was prescribed CLARITIN 10mg & Prednisone 20mg.